TREATMENT WITH BROADLY NEUTRALIZING ANTIBODIES IN CHILDREN WITH HIV IN BOTSWANA
Broadly neutralizing monoclonal antibodies (bNAbs) suppress HIV-1 RNA and may deplete residual viral reservoirs. We evaluated VRC01LS and 10-1074 as a treatment alternative to antiretroviral therapy (ART). Children who received continuous ART from 400 c/mL, or at 24 weeks; HIV RNA was checked weekly until